- Home
- ENVB vs APDN Comparison
ENVB vs APDN Comparison
Compare ENVB & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENVB
- APDN
- Stock Information
- Founded
- ENVB 1994
- APDN 1983
- Country
- ENVB United States
- APDN United States
- Employees
- ENVB N/A
- APDN N/A
- Industry
- ENVB Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- ENVB Health Care
- APDN Consumer Discretionary
- Exchange
- ENVB Nasdaq
- APDN Nasdaq
- Market Cap
- ENVB 3.1M
- APDN 2.7M
- IPO Year
- ENVB N/A
- APDN N/A
- Fundamental
- Price
- ENVB $1.15
- APDN $4.57
- Analyst Decision
- ENVB Strong Buy
- APDN
- Analyst Count
- ENVB 1
- APDN 0
- Target Price
- ENVB $10.00
- APDN N/A
- AVG Volume (30 Days)
- ENVB 179.6K
- APDN 164.7K
- Earning Date
- ENVB 08-11-2025
- APDN 08-11-2025
- Dividend Yield
- ENVB N/A
- APDN N/A
- EPS Growth
- ENVB N/A
- APDN N/A
- EPS
- ENVB N/A
- APDN N/A
- Revenue
- ENVB N/A
- APDN $3,790,616.00
- Revenue This Year
- ENVB N/A
- APDN $57.08
- Revenue Next Year
- ENVB N/A
- APDN $40.00
- P/E Ratio
- ENVB N/A
- APDN N/A
- Revenue Growth
- ENVB N/A
- APDN N/A
- 52 Week Low
- ENVB $1.01
- APDN $4.37
- 52 Week High
- ENVB $8.95
- APDN $2,655.00
- Technical
- Relative Strength Index (RSI)
- ENVB 35.60
- APDN 35.50
- Support Level
- ENVB $1.18
- APDN $4.90
- Resistance Level
- ENVB $1.26
- APDN $5.27
- Average True Range (ATR)
- ENVB 0.08
- APDN 0.38
- MACD
- ENVB -0.02
- APDN 0.05
- Stochastic Oscillator
- ENVB 3.10
- APDN 2.78
About ENVB Enveric Biosciences Inc.
Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.